Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-09

Clinical Trial Update: A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two semaglutide medicines in adults with Type 2 diabetes has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OZEMPIC (semaglutide)
  • Rybelsus (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2024-10-09